Trials / Completed
CompletedNCT05311488
Early Detection of Neuropathy in ATTRv
Early Detection of Peripheral Neuropathy in Hereditary Transthyretin Amyloidosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 47 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 30 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate and compare different tools that are used to detect evidence of peripheral neuropathy in patients with TTRv.
Detailed description
Early detection of peripheral neuropathy in patients with TTRv is important to support initiation of therapy that alters the course of the disease. Current tools used to detect peripheral neuropathy may not be sensitive, especially in very early and distal peripheral neuropathy. This study will compare different methods of assessing for peripheral neuropathy including using in-vivo reflectance confocal microscopy to assess for meissner corpuscles, serum neurofilament light chain, quantitative sensory testing, neuropathy impairement scores, nerve conduction studies and quality of life and symptoms questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | neurofilament light chain | Blood test |
| DIAGNOSTIC_TEST | In-vivo Meissner Corpuscle imaging | Imaging |
| DIAGNOSTIC_TEST | Nerve conduction study | Nerve conduction study |
Timeline
- Start date
- 2022-02-14
- Primary completion
- 2025-11-01
- Completion
- 2026-02-14
- First posted
- 2022-04-05
- Last updated
- 2026-03-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05311488. Inclusion in this directory is not an endorsement.